(S (NP-SBJ (NP (DT The) (ADJP (RB transcriptionally) (JJ active)) (NNS factors)) (VP (VBG mediating) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (NN HTLV-I) (NN Tax) (NN transactivator))) (PP (IN on) (NP (DT the) (NN IL-2R) (NN alpha) (NN kappa) (NN B) (NN enhancer)))))) (VP (VBP include) (NP (NP (DT the) (NN product)) (PP (IN of) (NP (DT the) (NN c-rel) (NN proto-oncogene))))) (. .))
(S (NP-SBJ (DT The) (NN transactivator) (NN HTLV-I) (NN Tax)) (VP (VBZ activates) (NP (NP (DT the) (NN promoter)) (PP (IN of) (NP (NP (DT the) (NN gene)) (VP (VBG coding) (PP (IN for) (NP (NP (DT the) (NN interleukin) (CD 2) (JJ alpha-chain) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN alpha)) (-RRB- -RRB-)))) (PP (IN via) (NP (NP (DT a) (NN kappa) (NN B) (NN site)) (SBAR (WHNP-38 (WDT that)) (S (NP-SBJ (-NONE- *T*-38)) (VP (MD can) (VP (VB bind) (NP (NP (JJ several) (NN protein) (NNS species)) (PP (IN of) (NP (DT the) (NN rel) (NN family))))))))))))))) (. .))
(S (NP-SBJ (NN Tax1)) (ADVP (RB strongly)) (VP (VBZ activates) (NP (NP (DT the) (NN enhancer) (NN activity)) (PP (IN of) (NP (DT this) (NN motif)))) (, ,) (PP (IN in) (NP (NP-COOD (CC both) (NP (JJ epithelial) (NN HeLa)) (CC and) (NP (JJ lymphoid) (NN Jurkat))) (NNS cells)))) (. .))
(S (NP-SBJ-39 (DT This) (NN activation)) (VP (VBD was) (RB not) (VP (VBN observed) (NP (-NONE- *-39)) (PP (IN in) (NP (JJ undifferentiated) (NN embryocarcinoma) (NN F9) (NNS cells))))) (. .))
(S (NP-SBJ (NP (NN Overexpression)) (PP (IN of) (NP (NP (DT the) (NP-COOD (NP (NN p50)) (, ,) (NP (NN p65)) (CC and) (NP (NN Rel))) (NNS proteins)) (PP (IN in) (NP (DT these) (NNS cells)))))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-40 (NP (JJ significant) (NN activation)) (PP (IN of) (NP (DT the) (NN IL-2R) (NN alpha) (NN kappa) (NN B) (NN site)))) (VP (VBD was) (VP (VBN observed) (NP (-NONE- *-40)) (PP (RB only) (IN with) (NP-COOD (NP (NN Rel)) (CC and) (NP-COOD (NP (NN Rel)) (CC plus) (NP (NN p65)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (SBAR (IN whereas) (S (NP-SBJ-COOD-41 (CC both) (NP (NN Tax)) (CC and) (NP (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-)))) (VP (VBP are) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-41)) (VP (TO to) (VP (ADVP (RB efficiently)) (VB induce) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (TO to) (NP (DT the) (NN IL-2R) (NN alpha) (NN kappa) (NN B) (NN site))))))))))) (, ,) (NP-SBJ (NN PMA)) (VP (VBZ is) (ADVP (RB functionally)) (ADJP-PRD (JJ inactive))) (. .))
(S (S (NP-SBJ (-NONE- *-42)) (VP (VBG Using) (NP (DT the) (NN DNA) (NN affinity) (NN precipitation) (NN assay)))) (, ,) (NP-SBJ-42 (PRP we)) (VP (VBD observed) (SBAR (IN that) (S-COOD (S (NP-SBJ-43 (NN Tax1)) (VP (VBZ is) (ADJP-PRD (JJ able) (S (NP-SBJ (-NONE- *-43)) (VP (TO to) (VP (ADVP (RB efficiently)) (VB induce) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN Rel)))))))))) (, ,) (IN whereas) (S (NP-SBJ (NN PMA)) (VP (VBZ is) (RB not) (ADJP-PRD (-NONE- *?*))))))) (. .))
(S (NP-SBJ-44 (DT This)) (VP (VBD established) (NP (NP (DT a) (JJ clear) (NN difference)) (PP (IN between) (NP (DT both) (NNS stimuli)))) (, ,) (S (NP-SBJ (-NONE- *-44)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NN Rel)) (VP (VBZ is) (NP-PRD (DT the) (ADJP (RB functionally) (JJ active)) (NN factor)))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP conclude) (PP (IN from) (NP (DT these) (NNS results))) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ-45 (NP (DT the) (JJ functional) (NN activity)) (PP (IN of) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NN rel) (NN family)))))) (VP (VBZ is) (VP (VBN regulated) (NP (-NONE- *-45)) (PP (IN by) (NP-LGS (NP (PRP$ their) (NN interaction)) (PP (IN with) (NP (NN DNA))))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NN Rel)) (VP (MD can) (VP (VB be) (NP-PRD (DT a) (JJ potent) (JJ transcriptional) (NN activator)) (PP (IN on) (NP (JJ specific) (NN kappa) (NN B) (NNS sites))))))))) (. .))
